These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 32270866)
61. Hsa_circ_0071589 aggravates stemness and oxaliplatin resistance in colorectal cancer through sponging miR-133b to upregulate SOX13 expression. Lv L; Yi L; Huang B; Zhou C; Zhang L Mol Cell Biochem; 2024 Aug; 479(8):2055-2068. PubMed ID: 37522976 [TBL] [Abstract][Full Text] [Related]
62. miR-506 enhances the sensitivity of human colorectal cancer cells to oxaliplatin by suppressing MDR1/P-gp expression. Zhou H; Lin C; Zhang Y; Zhang X; Zhang C; Zhang P; Xie X; Ren Z Cell Prolif; 2017 Jun; 50(3):. PubMed ID: 28217977 [TBL] [Abstract][Full Text] [Related]
63. Downregulation of AC092894.1 promotes oxaliplatin resistance in colorectal cancer via the USP3/AR/RASGRP3 axis. Zheng Z; Wu M; Li H; Xu W; Yang M; Pan K; Ni Y; Jiang T; Zheng H; Jin X; Zhang Y; Ding L; Fu J BMC Med; 2023 Apr; 21(1):132. PubMed ID: 37013584 [TBL] [Abstract][Full Text] [Related]
64. Pharmacological targeting PTK6 inhibits the JAK2/STAT3 sustained stemness and reverses chemoresistance of colorectal cancer. Liu C; Pan Z; Chen Q; Chen Z; Liu W; Wu L; Jiang M; Lin W; Zhang Y; Lin W; Zhou R; Zhao L J Exp Clin Cancer Res; 2021 Sep; 40(1):297. PubMed ID: 34551797 [TBL] [Abstract][Full Text] [Related]
65. MicroRNA-9 suppresses cell migration and invasion through downregulation of TM4SF1 in colorectal cancer. Park YR; Lee ST; Kim SL; Liu YC; Lee MR; Shin JH; Seo SY; Kim SH; Kim IH; Lee SO; Kim SW Int J Oncol; 2016 May; 48(5):2135-43. PubMed ID: 26983891 [TBL] [Abstract][Full Text] [Related]
66. P53‑microRNA interactions regulate the response of colorectal tumor cells to oxaliplatin under normoxic and hypoxic conditions. Zhang J; Li C; Sun L; Sun D; Zhao T Oncol Rep; 2023 Dec; 50(6):. PubMed ID: 37921068 [TBL] [Abstract][Full Text] [Related]
67. MicroRNA-411 inhibits malignant biological behaviours of colorectal cancer cells by directly targeting PIK3R3. Zhao J; Xu J; Zhang R Oncol Rep; 2018 Feb; 39(2):633-642. PubMed ID: 29207180 [TBL] [Abstract][Full Text] [Related]
68. KIF18b-dependent hypomethylation of PARPBP gene promoter enhances oxaliplatin resistance in colorectal cancer. Hong B; Lu R; Lou W; Bao Y; Qiao L; Hu Y; Liu K; Chen J; Bao D; Ye M; Fang Z; Gong C; Zhang X Exp Cell Res; 2021 Oct; 407(2):112827. PubMed ID: 34508743 [TBL] [Abstract][Full Text] [Related]
69. MiR-3622a-3p acts as a tumor suppressor in colorectal cancer by reducing stemness features and EMT through targeting spalt-like transcription factor 4. Chang S; Sun G; Zhang D; Li Q; Qian H Cell Death Dis; 2020 Jul; 11(7):592. PubMed ID: 32719361 [TBL] [Abstract][Full Text] [Related]
70. MiR-139-5p inhibits migration and invasion of colorectal cancer by downregulating AMFR and NOTCH1. Song M; Yin Y; Zhang J; Zhang B; Bian Z; Quan C; Zhou L; Hu Y; Wang Q; Ni S; Fei B; Wang W; Du X; Hua D; Huang Z Protein Cell; 2014 Nov; 5(11):851-61. PubMed ID: 25149074 [TBL] [Abstract][Full Text] [Related]
71. Decreased expression of LncRNA SLC25A25-AS1 promotes proliferation, chemoresistance, and EMT in colorectal cancer cells. Li Y; Huang S; Li Y; Zhang W; He K; Zhao M; Lin H; Li D; Zhang H; Zheng Z; Huang C Tumour Biol; 2016 Oct; 37(10):14205-14215. PubMed ID: 27553025 [TBL] [Abstract][Full Text] [Related]
72. CXCL12/CXCR4 axis induced miR-125b promotes invasion and confers 5-fluorouracil resistance through enhancing autophagy in colorectal cancer. Yu X; Shi W; Zhang Y; Wang X; Sun S; Song Z; Liu M; Zeng Q; Cui S; Qu X Sci Rep; 2017 Feb; 7():42226. PubMed ID: 28176874 [TBL] [Abstract][Full Text] [Related]
73. MiR-30-5p suppresses cell chemoresistance and stemness in colorectal cancer through USP22/Wnt/β-catenin signaling axis. Jiang S; Miao D; Wang M; Lv J; Wang Y; Tong J J Cell Mol Med; 2019 Jan; 23(1):630-640. PubMed ID: 30338942 [TBL] [Abstract][Full Text] [Related]
74. miR-375-3p suppresses tumorigenesis and partially reverses chemoresistance by targeting YAP1 and SP1 in colorectal cancer cells. Xu X; Chen X; Xu M; Liu X; Pan B; Qin J; Xu T; Zeng K; Pan Y; He B; Sun H; Sun L; Wang S Aging (Albany NY); 2019 Sep; 11(18):7357-7385. PubMed ID: 31543507 [TBL] [Abstract][Full Text] [Related]
75. MicroRNA-143 inhibits tumor growth and angiogenesis and sensitizes chemosensitivity to oxaliplatin in colorectal cancers. Qian X; Yu J; Yin Y; He J; Wang L; Li Q; Zhang LQ; Li CY; Shi ZM; Xu Q; Li W; Lai LH; Liu LZ; Jiang BH Cell Cycle; 2013 May; 12(9):1385-94. PubMed ID: 23574723 [TBL] [Abstract][Full Text] [Related]
76. Exosomal transfer of circular RNA FBXW7 ameliorates the chemoresistance to oxaliplatin in colorectal cancer by sponging miR-18b-5p. Xu Y; Qiu A; Peng F; Tan X; Wang J; Gong X Neoplasma; 2021 Jan; 68(1):108-118. PubMed ID: 33147048 [TBL] [Abstract][Full Text] [Related]
77. An aldehyde dehydrogenase 1A3 inhibitor attenuates the metastasis of human colorectal cancer. Duan JJ; Wang D; Cai J; Chen JJ; Zheng XX; Chen TQ; Wang J; Zhang X; Yang QK; Yu SC Cancer Lett; 2022 Jun; 536():215662. PubMed ID: 35331786 [TBL] [Abstract][Full Text] [Related]
78. MiR-744 mediates the Oxaliplatin chemoresistance in colorectal cancer through inhibiting BIN1. Zhou Y; He A; Zhang L; Yi G Neoplasma; 2020 Mar; 67(2):296-303. PubMed ID: 31884801 [TBL] [Abstract][Full Text] [Related]
79. Long noncoding RNA CCAL transferred from fibroblasts by exosomes promotes chemoresistance of colorectal cancer cells. Deng X; Ruan H; Zhang X; Xu X; Zhu Y; Peng H; Zhang X; Kong F; Guan M Int J Cancer; 2020 Mar; 146(6):1700-1716. PubMed ID: 31381140 [TBL] [Abstract][Full Text] [Related]
80. Emerging roles of non-coding RNAs in colorectal cancer oxaliplatin resistance and liquid biopsy potential. Luo ZD; Wang YF; Zhao YX; Yu LC; Li T; Fan YJ; Zeng SJ; Zhang YL; Zhang Y; Zhang X World J Gastroenterol; 2023 Jan; 29(1):1-18. PubMed ID: 36683709 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]